FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase

od Flamme, Ingo, Ellinghaus, Peter, Urrego, Diana, Krüger, Thilo
Izdano u PLoS One (2017)

Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects

od Flamme, Ingo, Oehme, Felix, Ellinghaus, Peter, Jeske, Mario, Keldenich, Jörg, Thuss, Uwe
Izdano u PLoS One (2014)

Novel Aspects of Fibrin(ogen) Fragments during Inflammation

od Jennewein, Carla, Tran, Nguyen, Paulus, Patrick, Ellinghaus, Peter, Eble, Johannes Andreas, Zacharowski, Kai
Izdano 2011

Deguelin Attenuates Reperfusion Injury and Improves Outcome after Orthotopic Lung Transplantation in the Rat

od Paulus, Patrick, Ockelmann, Pia, Tacke, Sabine, Karnowski, Nora, Ellinghaus, Peter, Scheller, Bertram, Holfeld, Johannes, Urbschat, Anja, Zacharowski, Kai
Izdano 2012

(18)F-FAZA PET imaging response tracks the reoxygenation of tumors in mice upon treatment with the mitochondrial complex I inhibitor BAY 87-2243

od Chang, Edwin, Liu, Hongguang, Unterschemmann, Kerstin, Ellinghaus, Peter, Liu, Shuanglong, Gekeler, Volker, Cheng, Zhen, Berndorff, Dietmar, Gambhir, Sanjiv S
Izdano u Clin Cancer Res (2014)

Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders

od Dinh, Wilfried, Füth, Reiner, Nickl, Werner, Krahn, Thomas, Ellinghaus, Peter, Scheffold, Thomas, Bansemir, Lars, Bufe, Alexander, Barroso, Michael Coll, Lankisch, Mark
Izdano 2009

Soluble P-selectin and matrix metalloproteinase 2 levels are elevated in patients with diastolic dysfunction independent of glucose metabolism disorder or coronary artery disease

od Füth, Reiner, Dinh, Wilfried, Nickl, Werner, Bansemir, Lars, Barroso, Michael Coll, Bufe, Alexander, Sause, Armin, Scheffold, Thomas, Krahn, Thomas, Ellinghaus, Peter, Lankisch, Mark
Izdano 2009

Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function

od Seedorf, Udo, Raabe, Martin, Ellinghaus, Peter, Kannenberg, Frank, Fobker, Manfred, Engel, Thomas, Denis, Simone, Wouters, Fred, Wirtz, Karel W.A., Wanders, Ronald J.A., Maeda, Nobuyo, Assmann, Gerd
Izdano 1998

Regorafenib (BAY 73-4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer

od Schmieder, Roberta, Hoffmann, Jens, Becker, Michael, Bhargava, Ajay, Müller, Tina, Kahmann, Nicole, Ellinghaus, Peter, Adams, Robert, Rosenthal, André, Thierauch, Karl-Heinz, Scholz, Arne, Wilhelm, Scott M, Zopf, Dieter
Izdano u Int J Cancer (2014)

BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I

od Ellinghaus, Peter, Heisler, Iring, Unterschemmann, Kerstin, Haerter, Michael, Beck, Hartmut, Greschat, Susanne, Ehrmann, Alexander, Summer, Holger, Flamme, Ingo, Oehme, Felix, Thierauch, Karlheinz, Michels, Martin, Hess-Stumpp, Holger, Ziegelbauer, Karl
Izdano 2013

Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models

od Grünewald, Sylvia, Politz, Oliver, Bender, Sebastian, Héroult, Mélanie, Lustig, Klemens, Thuss, Uwe, Kneip, Christoph, Kopitz, Charlotte, Zopf, Dieter, Collin, Marie‐Pierre, Boemer, Ulf, Ince, Stuart, Ellinghaus, Peter, Mumberg, Dominik, Hess‐Stumpp, Holger, Ziegelbauer, Karl
Izdano u Int J Cancer (2019)